We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+20.65%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
+$24.3M
(+32%)
Cap. Flow
+$6.54M
Cap. Flow
% of AUM
6.51%
Top 10 Holdings %
Top 10 Hldgs %
56.12%
Holding
218
New
50
Increased
37
Reduced
21
Closed
27
Avg Time Held Equity + Options
4.4
quarters
Top 10 Avg Time Held Equity + Options
1.9
quarters
Top 20 Avg Time Held Equity + Options
2.2
quarters
Avg Time Held Equity only
4.7
quarters
Top 10 Avg Time Held Equity only
2.6
quarters
Top 20 Avg Time Held Equity only
2.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.77M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$661K |
| 3 |
Agios Pharmaceuticals
AGIO
|
+$653K |
| 4 |
Micron Technology
MU
|
+$610K |
| 5 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$487K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.06M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$823K |
| 3 |
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
|
+$578K |
| 4 |
BVA
CORDIA BANCORP INC COM
BVA
|
+$499K |
| 5 |
Opko Health
OPK
|
+$349K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 43.64% |
| 2 | Miscellaneous | 21.13% |
| 3 | Healthcare | 14.92% |
| 4 | Technology | 7.13% |
| 5 | Consumer Discretionary | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MR
101
DELISTED
Montage Resources Corporation Common Stock
MR
| $132K | 0.13% |
2,667
-666
| -20% | -$31.9K |
2016 Q2
1 quarter
|
|
102
DELISTED
Vonage Holdings Corporation
VG
| $132K | 0.13% |
+20,000
| New | +$120K |
2016 Q3
0 quarters
|
|
103
Exelixis
EXEL
$15.1B
| $128K | 0.13% |
+10,000
| New | +$108K |
2016 Q3
0 quarters
|
|
104
DELISTED
S&W Seed Co
SANW
| $128K | 0.13% |
1,316
| – | – |
2015 Q1
6 quarters
|
|
105
Crocs
CROX
$5.65B
| $125K | 0.12% |
15,000
+5,000
| +50% | +$47.9K |
2016 Q2
1 quarter
|
|
106
Iovance Biotherapeutics
IOVA
$6.64B
| $123K | 0.12% |
15,000
+5,000
| +50% | +$42.3K |
2016 Q2
1 quarter
|
|
107
Arcos Dorados Holdings
ARCO
$1.62B
| $119K | 0.12% |
23,126
| – | – |
2016 Q2
1 quarter
|
|
108
Vince Holding Corp
VNCE
$150M
| $113K | 0.11% |
+2,000
| New | +$114K |
2016 Q3
0 quarters
|
|
|
BBG
109
DELISTED
Bill Barrett Corp
BBG
| $111K | 0.11% |
+20,000
| New | +$119K |
2016 Q3
0 quarters
|
|
110
Itaú Unibanco
ITUB
$111B
| $109K | 0.11% |
22,676
| – | – |
2016 Q2
1 quarter
|
|
|
KLREU
111
DELISTED
KLR Energy Acquisition Corp.
KLREU
| $105K | 0.1% |
10,000
| – | – |
2016 Q1
2 quarters
|
|
112
Novavax
NVAX
$2.05B
| $104K | 0.1% |
+2,500
| New | +$323K |
2016 Q3
0 quarters
|
|
113
CALL
Pacific Biosciences
PACB
$634M
| $90K | 0.09% |
+10,000
| New | +$83.6K |
2016 Q3
0 quarters
|
|
114
DELISTED
Patriot National, Inc.
PN
| $90K | 0.09% |
+10,000
| New | +$87.1K |
2016 Q3
0 quarters
|
|
115
San Juan Basin Royalty Trust
SJT
$184M
| $89K | 0.09% |
15,000
-10,000
| -40% | -$62.8K |
2016 Q2
1 quarter
|
|
|
MPVD
116
DELISTED
Mountain Province Diamonds Inc.
MPVD
| $79K | 0.08% |
+15,000
| New | +$74.2K |
2016 Q3
0 quarters
|
|
117
DELISTED
Enzo Biochem, Inc.
ENZ
| $76K | 0.08% |
15,000
-10,000
| -40% | -$59.7K |
2015 Q4
3 quarters
|
|
118
TherapeuticsMD
TXMD
$23.7M
| $68K | 0.07% |
+200
| New | +$73K |
2016 Q3
0 quarters
|
|
|
ACW
119
DELISTED
Accuride Corp
ACW
| $64K | 0.06% |
+25,000
| New | +$44.6K |
2016 Q3
0 quarters
|
|
120
Origin Agritech
SEED
$9.22M
| $59K | 0.06% |
+2,500
| New | +$53.2K |
2016 Q3
0 quarters
|
|
|
HGT
121
DELISTED
Hugoton Royalty Trust
HGT
| $59K | 0.06% |
25,000
| – | – |
2016 Q2
1 quarter
|
|
122
Alaunos Therapeutics
TCRT
$2.22M
| $56K | 0.06% |
+67
| New | +$53.9K |
2016 Q3
0 quarters
|
|
123
FuelCell Energy
FCEL
$1.29B
| $54K | 0.05% |
+28
| New | +$53.8K |
2016 Q3
0 quarters
|
|
124
Aware
AWRE
$22M
| $53K | 0.05% |
10,000
| – | – |
2013 Q4
11 quarters
|
|
125
Teekay Tankers
TNK
$3.76B
| $51K | 0.05% |
2,500
| – | – |
2014 Q1
10 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q3 2016 Portfolio in Review
As of Q3 2016, E.E. Geduld held 218 positions worth $100M, up 32% from $76M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
E.E. Geduld deployed $6.54M of net new capital in Q3 2016, opening 50 new positions and adding to 37 existing holdings. Its largest new stake was Agios Pharmaceuticals: 15,000 shares worth $792K.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 49% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Opko Health, an estimated $349K trimmed.
- E.E. Geduld's largest Q3 2016 buy was Agios Pharmaceuticals: 15,000 shares worth $792K.
- E.E. Geduld added most to Bristol-Myers Squibb in Q3 2016, an estimated $1.77M increase.
- E.E. Geduld's biggest Q3 2016 reduction was Opko Health, cutting an estimated $349K.
- E.E. Geduld fully exited Tesla in Q3 2016, selling an estimated $1.06M.
- E.E. Geduld's ten largest holdings make up 56% of its $100M portfolio in Q3 2016.
- E.E. Geduld opened 50 new positions and closed 27 in Q3 2016.
- E.E. Geduld's portfolio value rose 32% quarter-over-quarter to $100M.
Based on E.E. Geduld's 13F filing for Q3 2016, filed 2 Nov 2016.